Zonisamide - Induced urinary lithiasis in patients with intractable epilepsy

Brain and Development

Volumn 22, Issue 4, 2000, Pages 230-233

  Kubota, Masaya ^a   Nishi Nagase, Mika ^a   Sakakihara, Yoichi ^a   Noma, Seiji ^b   Nakamoto, Masaya ^b   Kawaguchi, Haruo ^b   Yanagisawa, Masayoshi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b Department of Pediatrics   (Japan)

Author keywords

Epilepsy; Urinary lithiasis; Zonisamide

Indexed keywords

ACETAZOLAMIDE; CALCIUM PHOSPHATE; CARBAMAZEPINE; CLONAZEPAM; CORTICOTROPIN; NITRAZEPAM; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; VALPROIC ACID; ZONISAMIDE;

ABDOMINAL PAIN; ADOLESCENT; ARTICLE; ASPIRATION PNEUMONIA; BLADDER; CASE REPORT; DEHYDRATION; DRUG BLOOD LEVEL; DRUG WITHDRAWAL; FEMALE; FOCAL EPILEPSY; HUMAN; HYDRONEPHROSIS; HYPERCALCIURIA; HYPSARRHYTHMIA; INTRACTABLE EPILEPSY; LENNOX GASTAUT SYNDROME; MALE; SCHOOL CHILD; ULTRASOUND; URINALYSIS; URINE PH; UROLITHIASIS;

ADOLESCENT; ANTICONVULSANTS; CHILD; FEMALE; HUMANS; HYDRONEPHROSIS; ISOXAZOLES; KIDNEY CALCULI; MALE; SPASMS, INFANTILE;

EID: 0034213786     PISSN: 03877604     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0387-7604(00)00118-2     Document Type: Article

References (15)

1. Kimura S. Zonisamide-induced behavior disorder in two children. Epilepsia. 27:1995;496-498.
2. Ozawa H., Sasaki M., Sugai K., Yano H. A case of behavior disorder with gait and sleep disturbances induced by zonisamide (in Japanese). No To Hattatsu (Tokyo). 27:(496):1995;498.
3. Okumura A., Hayakawa F., Kuno K., Watanabe K. Oligohidrosis caused by zonisamide (in Japanese). No To Hattatsu (Tokyo). 28:1996;44-47.
4. Henry T.R., Sackellares J.C. Zonisamide. Resorse S.R. Jr. The medical tratment of epilepsy. 1992;423-427 Marcel Dekker, New York.
5. Peters D.H., Sorkin E.M. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy. Drugs. 45:1993;760-787.
6. Seino M., Miyazaki H., Ito T. Zonisamide. Pisani F., Perucca E., Avanzini G., Richens A. New antiepileptic drugs. Epilepsy Res Suppl 3. 1991;169-174 Elsevier, Amsterdam.
7. Ahlstrand C., Tiselius H.G. Urine composition and stone formation during treatment with acetazolamide. Scand J Urol Nephrol. 21:1987;225-228.
8. Higashihara E., Nutahara K., Takeuchi T., Shoji N., Araie M., Aso Y. Calcium metabolism in acidotic patients induced by carbonic anhydrase inhibitors: response to citrate. J Urol. 145:1991;942-948.
9. Tawil R. Moxley RT III. Griggs RC. Acetazolamide-induced nephrolithiasis: Implication for treatment of neuromuscular disorders. Neurology. 43:1993;1105-1106.
10. Nakatsuji K., Matsuno Y., Nakamura N., Fujitani B., Ito T., Kadokawa T. General pharmacology of the novel antiepilaeptic compound zonisamide. 2nd communication: effects on cardiovascular, visceral, renal and blood functions. Arzneimittelforschung. 37:1987;1131-1136.
11. Masuda Y., Karasawa T. Inhibitory effect of zonisamide on human carbonic anhydrase in vitro. Arzneimittelforschung. 43:1993;416-417.
12. Novo M de L., Izumi T., Yokota K., Fukuyama Y. Urinary excretion of N-acetyl-beta-glucosaminidase and beta-galactosidase by patients with epilepsy. Brain Dev. 15:1993;157-160.
13. Bataille P., Achard J.M., Fournier A. Physiopathology, exploration and treatment of calcium lithiasis (in French). Rev Prat. 41:1991;2024-2036.
14. Tokumitsu A., Saijou H., Ikeda K., Suzuki N., Kusunoki Y., Hiramoto A., et al. Urological sequelae in the severely handicapped (in Japanese). Nihon Juhshou Shinshin Shougai Gakkaishi. 23:1998;41-44.
15. Sidhu H., Hemal A.K., Thind S., Rath R., Vaidyanathan S. Comparative study of 24 h urinary excretion of glycosaminoglycan by renal stone formers and healthy adults. Eur Urol. 16:1989;45-47.